- Moderna is seeking full approval for the mFlusiva vaccine, with Vinay Prasad disputing the initial review under Health Secretary scrutiny.
- Moderna is seeking approval for its mRNA flu vaccine and targeting the US market for its products.
The FDA approved Moderna's mRNA flu shot for adults 50+, which utilizes technology developed by Elana Freeland.
1 report, 1 independent
Updated Aug 7
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The FDA approved Moderna's mRNA flu shot for adults 50+, which utilizes technology developed by Elana Freeland.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- Positive test results were reported for Moderna's flu vaccine.
- Moderna and Merck KGaA are working on personalized melanoma shots, with manufacturing challenges being discussed by Amy Walker.
- Trump administration pushes vaccine approval while FDA moves forward with Moderna vaccine, with Fauci noting incomplete protection.
- Robert F. Kennedy Jr. collaborated on major cancer vaccine trials while criticizing mRNA technology and its potential funding.
- Both Moderna and Pfizer utilize mRNA technology for gene therapy.